转录基因分析预测了易性皮肤中mTOR抑制剂的增强代谢活性和治疗潜力
Mackenzie L Sennett1, George W Agak2, Diane M Thiboutot1
1Department of Dermatology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
JID innovations : skin science from molecules to population health
|September 23, 2024
概括
容易的皮肤在免疫力和新陈代谢方面表现出明显的分子差异. mTOR抑制剂显示出在非损伤性皮肤中正常化基因表达的潜力,这表明了新的治疗途径.
科学领域:
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 目前的治疗专注于预防病变,但缺乏了解容易发生的皮肤中潜在的分子变化.
- 在患者 (NLA) 的非损伤性 (NL) 皮肤中,人们对可能导致病变发展的分子特征知之甚少.
研究的目的:
- 将患者的NL皮肤的基因表达特征与健康对照进行比较.
- 确定分子通路和潜在的治疗化合物,可以使NLA皮肤基因表达正常化.
主要方法:
- 在49名患者和19名健康对照的NL皮肤样本上进行了RNA测序.
- 使用了差异基因表达分析,基因组丰富分析和连接映射.
- 集成基于网络的签名库被用来识别潜在的治疗化合物.
主要成果:
- 在NLA皮肤中发现了77个差异表达的基因,包括与先天免疫和表皮屏障功能相关的基因.
- 代谢途径得到丰富,而NLA皮肤中的角质化被负面丰富.
- 187种化合物,特别是mTOR抑制剂,被确定为可能使NLA皮肤的基因表达特征正常化.
结论:
- NLA皮肤在表皮分化,新陈代谢和先天免疫力方面表现出独特的差异,有助于病变的形成.
- mTOR 抑制剂可能会使 NLA 皮肤恢复到更健康的状态,可能会逆转倾向.
- 这项研究提供了对容易的皮肤分子基础的见解,并提出了新的治疗策略.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K


